Carl Zeiss Meditec AG: Carl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft Surgery

Carl Zeiss Meditec AG / Carl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft Surgery . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

INFRARED 800 and FLOW 800 Fluorescence Modules showcased at the upcoming EURAPS 2012

JENA/Germany, 25 May 2012
The INFRARED 800 and FLOW^® 800 fluorescence modules from medical technology provider Carl Zeiss Meditec enable neurosurgeons to interpret the speed and direction of the blood flow precisely and quickly during surgery. This technology is also available for plastic & reconstructive surgery in the assessment of viable tissue useful in graft surgery. This technological advancement enables surgeons to evaluate tissue grafts perfusion before transplantation. Vascular occlusions become visible within a few seconds and can be immediately treated intraoperatively.

At the meeting of the European Association of Plastic Surgeons (EURAPS) taking place from May 24 to 28, 2012 in Munich, Germany, Carl Zeiss will present to the medical community this innovative fluorescence technology on its surgical microscope platform, OPMI PENTERO^® 900.

Initial study results confirm the benefits for plastic and reconstructive surgery

Initial studies have confirmed the benefits of intraoperative fluorescence technology for plastic surgery, in particular for flap grafts.

"The integration of fluorescence technology into the surgical microscope offers the surgeon more safety and certainty in clinically ambiguous situations during the procedure. Blood flow anomalies can be quickly detected, and the required surgical interventions initiated immediately. The method can predict the complication-free healing of skin and tissue grafts and provide initial indications of thrombosis," says Prof. Dr. med. Riccardo Giunta of the Ludwig-Maximilians University in Munich, Germany. Dr. Giunta and his colleagues worked with FLOW 800 on the publication titled "Intraoperative indocyanine green fluorescence diagnostics using a surgical microscope in plastic surgery" published in April 2012 in the journal Handchirurgie Microchirurgie Plastische Chirurgie (Holzbach T et al. 2012: Handchir Microchir Plast Chir 44, 84-88).

"We are pleased that we can now expand the fields of application for our fluorescence methods and therefore also assist doctors in plastic and reconstructive surgery in providing their patients with even better treatment," says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. "The results of the studies are very promising as they underscore the clinical benefit and innovation potential of the methods for use in different applications."

Fluorescence technology fully integrated into surgical microscope of Carl Zeiss

The fluorescence modules INFRARED 800 and FLOW 800 are completely integrated into the OPMI PENTERO surgical microscope platform enabling an optimal clinical workflow and outcome.

With INFRARED 800, all relevant information is displayed quickly and clearly on the integrated display during the surgery. The perfusion status can be immediately determined by visualizing the blood flow simply and on-demand.

FLOW 800 enables fast, clear presentation of the data. Selected areas can be analyzed even more exactly using curve diagrams, and blood flow anomalies quickly identified using comparative displays.

Further information on intraoperative fluorescence technology from Carl Zeiss is available at www.meditec.zeiss.com/iof (http://www.meditec.zeiss.com/iof)

Press contact

Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss Meditec AG
Phone. [phone], Email: [e-mail]
Analyst/Investor contact
Henriette Meyer, Director Investor Relations, Carl Zeiss Meditec AG
Phone [phone], Email: [e-mail]


www.meditec.zeiss.de (http://www.meditec.zeiss.de/)/presse

---

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Carl Zeiss Meditec AG via Thomson Reuters ONE

HUG#1615050

--- End of Message ---

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany

WKN: 531370;ISIN: DE0005313704;Index:Prime All Share,TECH All Share,TecDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;